AGBT GM
AGBT GM 5-8 February 2024 Orlando, Florida
Entries by 3dgenoxdt
Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer
Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships
Festival of Genomics
Festival of Genomics 24-25 January, 2024 London, UK
Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer
Key appointment supports company growth and strategic commercial and academic partnerships Cambridge, UK, 06 November 2023: Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Hazel Jones as Chief Operating Officer. Following a £10 million Series A financing in October 2022, […]
BioEquity Europe
BioEquity Europe 15-16 May 2023 Dublin, Ireland
Anglonordic Life Science Conference
Anglonordic Life Science Conference 5 May 2023 London, UK
OnHelix conference
We had a great day at OnHelix conference held at Babraham Institute focussed on translating research into diagnostics and therapeutics. #onhelix22 #3DGenomics
ENHANC3D was spun out of Professor Peter Fraser’s pioneering 3D genome organisation research laboratory
We are developing a technology to unlock the full potential of the 3D organisation of the #humangenome to identify #disease-associated #genetic interactions including those that are causal for disease susceptibility and progression.
ENHANC3D GENOMICS Awarded QuickFire Challenge Grant
We are proud to be awarded the Johnson & Johnson Innovation QuickFire Challenge Grant which recognises the potential of our functional genomics platform, GenLink3D™.